Library / Laws / 114th Congress / Senate Bills / S. 1421
S. 1421
To amend the Federal Food, Drug, and Cosmetic Act to authorize a 6-month extension of certain exclusivity periods in the case of approved drugs that are subsequently approved for a new indication to prevent, diagnose, or treat a rare disease or condition, and for other purposes.
| Print stage | Date | Size | ⠃ |
|---|---|---|---|
| Introduced in Senate | 2015-05-21 | 7.7K | ⠃⠗⠋ |